Not ideal when youre dealing with side effects. Mark D., verified user It is worth noting that most of these complaints are not unique to WeightWatchers as they are common across nearly all GLP-1 telehealth platforms, given the current demand for these medications
Do Not Speak with Manufacturer Representatives
Pini A, Garella R, Idrizaj E, Calosi L, Baccari MC, Vannucchi MG
NICE guidance (NG28) recommends structured follow-up for patients on GLP-1 therapy, with specific continuation criteria that must be met to justify ongoing treatment
This, at its core, has been a military enterprise
As the drug manufacturers Novo Nordisk and Eli Lilly have made exceedingly clear, these medicines are intended as long-term commitments, like medication for high blood pressure